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Purpose: Retinitis pigmentosa (RP) is a clinically and genetically heterogeneous retinal disorder. Despite tremendous
knowledge about the genes involved in RP, little is known about the genetic causes of RP in Indonesia. Here, we aim to
identify the molecular genetic causes underlying RP in a small cohort of Indonesian patients, using genome-wide
homozygosity mapping.
Methods: DNA samples from affected and healthy individuals from 14 Indonesian families segregating autosomal
recessive, X-linked, or isolated RP were collected. Homozygosity mapping was conducted using Illumina 6k or Affymetrix
5.0 single nucleotide polymorphism (SNP) arrays. Known autosomal recessive RP (arRP) genes residing in homozygous
regions and X-linked RP genes were sequenced for mutations.
Results: In ten out of the 14 families, homozygous regions were identified that contained genes known to be involved in
the pathogenesis of RP. Sequence analysis of these genes revealed seven novel homozygous mutations in ATP-binding
cassette, sub-family A, member 4 (ABCA4), crumbs homolog 1 (CRB1), eyes shut homolog (Drosophila) (EYS), c-mer
proto-oncogene  tyrosine  kinase  (MERTK),  nuclear  receptor  subfamily  2,  group  E,  member  3  (NR2E3)  and
phosphodiesterase 6A, cGMP-specific, rod, alpha (PDE6A), all segregating in the respective families. No mutations were
identified in the X-linked genes retinitis pigmentosa GTPase regulator (RPGR) and retinitis pigmentosa 2 (X-linked
recessive; RP2).
Conclusions: Homozygosity mapping is a powerful tool to identify the genetic defects underlying RP in the Indonesian
population. Compared to studies involving patients from other populations, the same genes appear to be implicated in the
etiology of recessive RP in Indonesia, although all mutations that were discovered are novel and as such may be unique
for this population.
Retinitis pigmentosa (RP), a group of clinically diverse
progressive retinal disorders, is a major cause of inherited
blindness,  affecting  1.5  million  people  worldwide.  RP  is
initially  characterized  by  night  blindness,  followed  by  a
gradual loss of peripheral vision and eventually leading to
legal blindness [1]. Generally, the manifestation of the first
symptom occurs in childhood or early adulthood. The main
clinical  characteristics  of  RP  are  bone-spiculed
pigmentations, attenuation of retinal vessels, a waxy pallor
appearance of the optic disc, and absent or severely reduced
a-waves on electroretinography.
Correspondence  to:  Rob  W.J.  Collin,  Department  of  Human
Genetics,  Radboud  University  Nijmegen  Medical  Centre,  Geert
Grooteplein 10 6525 GA Nijmegen, the Netherlands; Phone: +31 24
3617431; FAX: +31 24 3668752; email: r.collin@antrg.umcn.nl
Genetically,  RP  is  also  very  diverse,  with  over  50
different causative genes identified to date, and is inherited in
an autosomal dominant (30%–40%), an autosomal recessive
or isolated (50%–60%), an X-linked (5%–20%), or very rarely
in a mitochondrial or digenic manner [2]. Due to the relatively
high  rate  of  marriages  within  specific  ethnic  groups,
autosomal recessive inheritance was reported to be even more
frequent  in  Indonesia  [3].  A  significant  fraction  of  the
causative autosomal recessive RP (arRP) genes have been
identified  using  homozygosity  mapping  in  large,  often
consanguineous, pedigrees. Recently, we also applied high-
resolution  homozygosity  mapping  to  identify  the  genetic
defect underlying arRP in non-consanguineous populations
[4-7]. Despite a tremendous knowledge on the genetic causes
of RP, little is known about the genes involved in RP in the
Indonesian population. A study published earlier this year
involved the analysis of rhodopsin (RHO) in families with an
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3013autosomal  dominant  mode  of  inheritance  [8].  Here  we
describe  the  molecular  genetic  analysis  of  14  Indonesian
families  segregating  arRP  and  show  that  homozygosity
mapping is a powerful tool to identify causative mutations in
this population.
METHODS
Subjects: Fourteen Indonesian families segregating RP—13
living on Java and one on Sulawesi islands—were enrolled in
the study (total number of 56 individuals, 33 affected, 23
unaffected). The affected individuals were 20 males and 13
females of 10–71 years old, with the onset of the disease
ranging from the age of 5 to 25. All families appear to be
autosomal recessive, except for W09–0049, which is more
suggestive  of  an  X-linked  recessive  pattern.  This  type  of
inheritance is also possible in families W09–0048 and W09–
0050 (Figure 1). Affected individuals were diagnosed at the
Kariadi Hospital, the William Booth Hospital, or the Panti
Wilasa Citarum in Semarang Central Java, Indonesia, and
examined by direct ophthalmoscopy and visual acuity tests
using a Snellen chart. The presumed mode of inheritance was
determined by anamnesis and pedigree analysis. Informed
consent was obtained from all participating individuals or in
the case of under-age participants, from their parents. This
study adhered to the tenets of the Declaration of Helsinki. In
addition,  149  ethnically  matched  and  unrelated  control
individuals participated in this study.
Clinical  characterization:  Clinical  characterization  that
included  funduscopy  and  visual  acuity  measurements
revealed that the majority of affected individuals had poor
vision and showed typical hallmarks of RP on funduscopy,
e.g., bone-spicule pigmentation, attenuated retinal vessels,
and/or a pale appearance of the optic disc (Table 1). Only in
family  W09–0036  is  the  visual  acuity  not  dramatically
decreased.
Linkage analysis and homozygosity mapping: Genomic DNA
of  participating  individuals  was  isolated  from  peripheral
blood using a standard salting out procedure [9]. Affected
individuals were selected for genome-wide single nucleotide
polymorphism  (SNP)  analysis.  For  three  consanguineous
families (W09–0041, W09–0042, and W09–0046), the low-
resolution Illumina 6k SNP array (Illumina, San Diego, CA)
that contains 6,020 SNPs was used, whereas the patients from
the  remaining  11  families  were  genotyped  on  a  high-
resolution Affymetrix 5.0 array (Affymetrix, Santa Clara, CA)
that contains ~500,000 SNPs. For the three consanguineous
families that were analyzed on the Illumina array, multipoint
parametric  linkage  analysis  was  performed  using  the
GeneHunter 2.1r5 program in the easyLinkage v5.052beta
software package [10]. For the other families, homozygous
regions were calculated using PLINK software [11], with a
cut-off of 3 Mb and allowing two heterozygous SNP calls per
window of 50 SNPs.
Mutation analysis: Exons and intron–exon boundaries of all
known arRP genes residing in homozygous regions and X-
linked  RP  genes  retinitis  pigmentosa  GTPase  regulator
(RPGR)  and  retinitis  pigmentosa  2  (X-linked  recessive)
(RP2) were sequenced in the corresponding probands using
the Big Dye Terminator Cycle Sequencing Kit v3.1 on a 3130
automated sequencer (Applied Biosystems, Foster City, CA).
Upon identification of an unknown variant, available family
members and/or ethnically matched control individuals were
analyzed using direct sequencing, the amplification refractory
mutation system or restriction fragment length polymorphism
analysis. Primer sequences and PCR conditions are available
upon request. The analysis of mutations was conducted with
AlaMut  1.5  software  (Interactive  Biosoftware,  Rouen,
France). Splice site scores were calculated using an internal
AlaMut module that combines the scores of GeneSplicer,
MaxEntScan, SpliceSiteFinder-like, and NNSPLICE. For the
missense  changes  that  were  identified,  the  evolutionary
conservation of the substituted amino acids was assessed by
aligning  the  corresponding  protein  sequences  of  several
species, using the Align program in VectorNTI Advance 11.0
software (Invitrogen, Carlsbad, CA). The pathogenicity of
these  mutations  was  evaluated  using  SIFT  [12]  and
PolyPhen-2 [13] prediction programs. In addition, Grantham
scores, which define the physicochemical difference between
amino acids [14], and PhyloP scores, which are a measure of
evolutionary  nucleotide  conservation  (PhyloP44wayAll),
were determined.
RESULTS
Linkage  analysis  and  homozygosity  mapping  in  arRP
families: To determine the location of the genetic defect in the
14  presumed  arRP  families,  affected  individuals  were
genotyped using whole-genome SNP arrays (Figure 1). In
three  consanguineous  families  with  multiple  affected
individuals  (W09–0041,  W09–0042,  and  W09–0046),  the
Illumina 6k array was used. Multipoint linkage analysis was
performed to detect genomic regions that might contain the
genetic defect. In family W09–0041, only a single peak with
a maximum multipoint LOD score of 3.00 on chromosome 15
was identified (Figure 2A). In families W09–0042 and W09–
0046, multiple peaks potentially harboring the genetic defect
were identified, with multipoint LOD scores of 1.80 (Figure
2B,C). As expected in patients born from consanguineous
marriages, all regions with the highest LOD scores in the three
families  represented  continuous  stretches  of  homozygous
SNP calls (Table 2), with identical haplotypes shared between
affected siblings. In the remaining 11 arRP families, high-
resolution SNP genotyping was performed using Affymetrix
5.0  arrays.  Homozygous  regions  were  calculated  and
considered to be significant if they spanned more than 3 Mb
of genomic DNA. For the families with multiple affected
siblings,  only  those  regions  that  were  homozygous  in  all
affected individuals were considered to potentially harbor the
Molecular Vision 2011; 17:3013-3024 <http://www.molvis.org/molvis/v17/a325> © 2011 Molecular Vision
3014Figure 1. Overview of the pedigree structure of the Indonesian families participating in this study. Affected individuals are indicated with
filled symbols, whereas unaffected relatives are indicated by open symbols. Symbols with a slash depict deceased individuals. Probands are
indicated with arrows, and individuals that were genotyped on genome-wide SNP arrays are marked with asterisks. Upon the identification
of mutations in the probands (gene and mutation indicated below the pedigree), segregation analysis was performed in all available relatives,
the results of which are indicated with M (mutated allele) or + (wild-type allele).
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3016causative  gene.  In  four  families,  no  regions  that  were
homozygous in all affected siblings were identified, whereas
in a few other families, many of those regions were present.
In  the  non-consanguineous  families,  the  number  of
homozygous segments per family varied from 0 to 5, with a
maximum length of 20 Mb.
Mutation  analysis  of  autosomal  recessive  RP  genes  in
homozygous regions: In the majority of the families, one or
more homozygous regions contained one of the 31 known
arRP  genes.  Sequence  analysis  of  these  genes  in  the
corresponding families revealed seven novel mutations likely
to be causative for RP in the respective families (Table 2). The
pathogenicity of the missense and splice site mutations were
evaluated using a detailed in silico analysis (Table 3).
In  family  W09–0038,  the  largest  homozygous  region
contained  the  c-mer  proto-oncogene  tyrosine  kinase
(MERTK) gene. Exon 15 failed to amplify in the affected
individuals  but  not  in  the  unaffected  family  members,
suggesting a genomic deletion (Figure 3A). Detailed analysis
revealed  the  occurrence  of  a  complex  rearrangement  that
included a 1732-bp deletion containing exon 15 of MERTK
(Figure 3B). The absence of exon 15 from MERTK mRNA is
predicted to result in a frameshift and premature stop codon,
which  may  lead  to  truncation  of  the  MERTK  protein
(p.G654AfsX41) or trigger nonsense-mediated mRNA decay.
The affected individuals of family W09–0045 displayed three
shared  homozygous  regions,  of  which  the  second  largest
contained  MERTK.  Sequence  analysis  revealed  a
homozygous  mutation  (c.2487–2A>G)  that  affects  the
consensus splice site of exon 19 and most likely results in
aberrant splicing and premature termination of the MERTK
protein,  including  the  highly  conserved  tyrosine  kinase
domain (Table 3).
In family W09–0041, four affected siblings shared only
one large homozygous region, on chromosome 15, harboring
the  nuclear  receptor  subfamily  2,  group  E,  member  3
(NR2E3)  gene.  Mutation  analysis  of  NR2E3  identified  a
homozygous  mutation  substituting  a  glycine  for  a  valine
residue  (c.1025T>G;  p.V342G).  The  PolyPhen-2  program
predicts  this  variant  to  be  probably  damaging,  and  SIFT
indicates that in this position only a valine or isoleucine is
tolerated  (Table  3).  Furthermore,  the  mutation  was
homozygously present in five affected family members and
was  absent  or  heterozygously  present  in  three  unaffected
siblings.  Finally,  this  variant  was  not  detected  in  298
ethnically  matched  control  alleles.  NR2E3  encodes  a
transcription  factor  that  belongs  to  the  family  of  nuclear
hormone receptors, with a DNA-binding domain (DBD) at the
N-terminus and a ligand-binding domain (LBD) located more
C-terminally [15]. Most NR2E3 mutations that cause retinal
dystrophy affect amino acid residues located in these two
domains [16]. The LBD of NR2E3 is structurally similar to
that of other nuclear hormone receptor family members and
consists of 12 structurally conserved α-helices [17,18]. The
valine residue at position 342 is highly conserved, both in the
NR2E3 proteins of other species and in the LBD of other
nuclear hormone receptors, being either a valine or a similar
isoleucine residue in all other protein sequences (Figure 4B).
This high degree of conservation suggests that a relatively
large nonpolar amino acid must be present at this position to
preserve the structure and/or function of the LBD of these
proteins. The glycine residue that is present in the mutant
NR2E3 protein is small and might interrupt the structure and
render the protein inactive or partially active. The pathogenic
character of this variant is supported by the fact that this
alteration has not been found in alleles of healthy ethnically
matched individuals.
In  family  W09–0042,  the  largest  homozygous  region
contains the ATP-binding cassette, sub-family A, member 4
(ABCA4) gene, which has been associated with Stargardt's
disease [19], cone-rod dystrophy, and to a lesser extent, RP
[20]. Sequence analysis revealed a nucleotide variant in the
splice  donor  site  of  exon  3  (c.302+4A>C)  homozygously
present  in  the  two  affected  siblings  and  absent  or
heterozygously  present  in  their  nonaffected  relatives.  In
addition,  the  variant  was  not  detected  in  298  ethnically
matched  control  chromosomes.  In  silico  prediction  of  the
strength of the splice donor site showed a decrease due to the
alteration  (e.g.,  40%  decrease  in  GeneSplicer,  24%  in
MaxEntScan,  12.3%  SpliceSiteFinder-like,  and  0.04%
decrease in NNSPLICE), indicating that this variant might
alter  ABCA4  splicing  (Table  3).  However,  due  to  the
unavailability of patient RNA or lymphoblastoid cell lines,
altered  ABCA4  splicing  could  not  be  confirmed  in  vivo.
Hence, the pathogenicity of this variant remains uncertain.
In  family  W09–0046,  three  regions  that  are
homozygously shared by two affected siblings were detected.
The second largest region contained two known arRP genes,
namely tubby-like protein 1 (TULP1) and eyes shut homolog
(Drosophila)  (EYS).  Sequence  analysis  of  TULP1  did  not
reveal any pathogenic variants, whereas a missense variant
was detected in EYS that segregated with arRP in the family
(c.9082G>T; p.D3028Y). This alteration affects an aspartic
acid residue localized in the fifth laminin A G-like domain of
the human EYS protein. The aspartic acid residue at this
position is also present in homologous positions of other EYS
LG domains and is evolutionarily conserved in EYS proteins
of  other  species  (Figure  4C).  Both  SIFT  and  PolyPhen-2
predict this change to be damaging, which is further supported
by high Grantham and PhyloP scores (Table 3). Intriguingly,
a similar mutation (p.D2767Y), located at the homologous
position in the fourth laminin A G-like domain of EYS, was
recently found in a Pakistani family segregating arRP [21].
This suggests that the aspartic acid residue located at that
position within the laminin A G-like domain is crucial for
proper functioning of EYS and that the p.D3028Y mutation
is indeed pathogenic in family W09–0046.
Molecular Vision 2011; 17:3013-3024 <http://www.molvis.org/molvis/v17/a325> © 2011 Molecular Vision
3017Figure 2. Overview of linkage plots for the three consanguineous Indonesian families. The graphs depict the linkage analysis results for three
consanguineous Indonesian families, W09–0041 (A), W09–0042 (B) and W09–0046 (C) that were analyzed with Illumina 6k arrays. The
highest LOD-score peaks were identified using EasyLinkage software. Peaks that correspond to the regions harboring the genes in which
mutations were identified, are indicated with red arrows.
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3020In two affected siblings from family W09–0047, only a
single homozygous region was detected that harbored the
phosphodiesterase 6A, cGMP-specific, rod, alpha (PDE6A)
gene.  A  nonsense  mutation  (c.1675C>A;  p.Y558X)  was
found to segregate with RP in this family, and this is predicted
to either result in premature termination of the α subunit of
the phosphodiesterase enzyme or to cause nonsense-mediated
decay of PDE6A mRNA.
The largest homozygous region detected in the affected
individual  50068  from  family  W09–0048  contained  the
crumbs  homolog  1  (CRB1)  gene,  and  sequence  analysis
revealed a transition of cytosine to thymine, resulting in the
substitution of a leucine for a proline residue (c.3914C>T;
p.P1305L). This alteration was not detected in 149 ethnically
matched control individuals and is predicted to be probably
damaging by PolyPhen, although the SIFT software predicts
it  to  be  tolerated  (Table  3).  The  proline  residue  that  is
substituted resides in one of the EGF-like calcium-binding
domains of CRB1 and neighbors one of the six core cysteine
residues that are essential for the formation of disulphide
bridges and proper structure of these domains [22]. The fact
that  the  proline  residue  is  highly  conserved  throughout
vertebrate evolution and even in fruit fly (Figure 4A), suggests
that this mutation is causative for arRP in this family.
Figure 3. Molecular genetic analysis of MERTK in family W09–0038. A: In the upper panel, PCR analysis of exon 15 of MERTK is shown.
Exon 15 was not amplified in the two affected individuals of family W09–0038. All relatives and their position in the pedigree are indicated
above the electropherogram. Lower panel: after identification of the breakpoints of the complex rearrangement, PCR primers were designed
to amplify a product spanning the deletion. A PCR product indicating the presence of a rearrangement is observed in all individuals
demonstrating that the unaffected family members are heterozygous carriers of the deletion. B: Schematic representation of the complex
rearrangement in MERTK. A deletion of a genomic region containing exon 15 is accompanied by a duplication and an inversion event.
Figure 4. Sequence comparison of amino acids mutated in Indonesian RP families. The mutated and flanking amino acids, from orthologous
and homologous protein sequences, for A: CRB1 B: NR2E3 and C: EYS. The arrows indicate the position of the mutated amino acid residue
in the alignment. Residues that are conserved in all protein sequences are depicted in white on a black background, whereas residues that are
conserved in more than 50% of the analyzed sequences are indicated in black on a gray background.
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3021In two of the families (W09–0049 and W09–0050), genes
residing  in  the  largest  homozygous  regions  (family  with
sequence  similarity  161,  member  A  [FAM161A],  ABCA4,
retinal pigment epithelium-specific protein 65 kDa [RPE65],
Usher syndrome 2A (autosomal recessive, mild) [USH2A],
and  progressive  rod-cone  degeneration  [PRCD])  were
excluded. Four families (W09–0036, W09–0039, W09–0040,
and W09–0044) had no significant homozygous regions.
For  the  families  with  plausible  X-linked  inheritance
(W09–0048,  W09–0049  and  W09–0050),  we  performed
screening of the two known X-linked RP genes. RP2 and
RPGR were sequenced, but no mutations were identified.
DISCUSSION
In this study we analyzed the molecular genetic causes of RP
in 14 Indonesian families with an apparent recessive mode of
inheritance;  especially  in  the  simplex  families,  de  novo
mutations or an X-linked inheritance cannot be ruled out.
In all 14 families, genome-wide homozygosity mapping
was performed to find genomic regions potentially harboring
the  causative  genetic  defect.  In  ten  of  the  14  families,
significant homozygous regions were detected in the affected
individuals, ranging from 3.4 to 69.5 Mb in size (Table 2). On
average, European populations, which are mostly outbred,
display  a  total  of  about  93  Mb  of  genomic  runs  of
homozygosity (ROH) longer than 0.5 Mb, corresponding to
approximately 3.5% of the genome [23]. Unfortunately, no
such  studies  were  conducted  within  the  Indonesian
population. In our small cohort, these average ROH in 16
individuals from nine families without reported consanguinity
(see Figure 1) comprised 146 Mb (~5.5%) of genomic DNA,
which suggests a slightly higher level of inbreeding in this
population.  Consanguineous  unions  within  the  Indonesian
culture are not uncommon. Moreover, Indonesia consists of a
large archipelago of islands, 922 of which are inhabited, which
further increases the possibility of marrying distant relatives.
Hence, our data support the hypothesis that the Indonesian
population  is  highly  suited  for  a  homozygosity  mapping
approach to determine genetic defects underlying recessive
diseases.
In nine families, the homozygous regions contained one
or more of the 31 known arRP genes. Sequence analysis of all
these  genes  in  the  corresponding  probands  revealed
potentially  pathogenic  mutations  in  seven  families.  A
homozygous nonsense mutation in PDE6A, a canonical splice
mutation  in  MERTK,  and  a  complex  rearrangement  in
MERTK are three mutations that are undoubtedly pathogenic
in the respective families. The causality of the novel three
missense and one splice donor mutation is not obvious. The
pathogenic effect of missense alterations may be difficult to
interpret in the absence of suitable functional assays or animal
models. However, due to the high degree of conservation of
the  mutated  amino  acid  residues,  their  location  within
predicted functional domains of the encoded proteins, and the
absence  of  these  alleles  in  ethnically  matched  control
individuals,  the  missense  variants  in  CRB1,  EYS,  and
NR2E3 are considered to be the probable pathogenic mutation
in the respective families. The splice alteration in ABCA4 (c.
302+4A>C) was also not detected in Indonesian controls, and
the  strength  of  the  splice  donor  site  was  predicted  to  be
decreased by several splice-site strength prediction programs.
The fourth nucleotide of an intron in primates is an adenine in
71% of the cases, a guanine in 12%, and a cytosine in only 8%
[24].  Therefore,  the  strength  of  the  splice  donor  site  in
ABCA4 may be reduced due to the A-to-C transition at that
position. However, reverse transcriptase (RT)-PCR analysis
on patient-derived RNA is necessary to confirm pathogenicity
of this variant in the respective family.
The identification of genetic events underlying RP was
previously  clinically  useful  only  in  genetic  counseling.
However, with the successful development of gene therapy
for retinal dystrophies, such as for Leber congenital amaurosis
due to RPE65 mutations [25-27], molecular diagnosis is of
increasing  importance  to  enroll  patients  in  future  clinical
trials. Since RP is a progressive disease, early diagnosis is
essential, and the identification of a causative alteration will
be crucial in the near future to plan gene- or even mutation-
tailored  therapy.  Homozygosity  mapping  has  been
demonstrated  to  be  a  powerful  tool  to  detect  recessive
mutations underlying RP in the Indonesian population. Based
upon the criteria of the percentage of homozygous regions in
an individual genome, which is about 50% higher than in
outbred European populations, SNP array analysis appears to
be the most practical approach. Since we have identified the
probable causative genetic defect in seven out of 14 arRP
families, using homozygosity mapping, and excluded RPGR
and RP2 in families suggestive of X-linked inheritance, some
of the other families might harbor a homozygous mutation in
a  novel  arRP  gene,  in  any  of  their  homozygous  regions.
However, many of the genetically unsolved families are non-
consanguineous  and  do  not  display  large  homozygous
regions. Therefore, the majority of these families are likely to
carry compound heterozygous mutations, either in one of the
known arRP genes or in yet to be identified genes. Only next-
generation  sequencing  approaches,  either  on  predefined
genomic regions [28] or unbiased exome sequencing [29,30],
will allow a cost- and time-efficient analysis to discover the
genetic causes underlying RP in the remaining families.
Due to the extreme heterogeneity of arRP, it is not easy
to predict the percentage of arRP cases that can be explained
by  mutations  in  the  known  arRP  genes,  although  current
estimates are around 50%. Being aware of the relatively small
size of our cohort but taking into consideration that some of
the  14  tested  arRP  families  may  carry  compound
heterozygous mutations in known arRP genes or homozygous
mutations in these genes in homozygous regions smaller than
3 Mb, we can conclude that the known arRP genes appear to
Molecular Vision 2011; 17:3013-3024 <http://www.molvis.org/molvis/v17/a325> © 2011 Molecular Vision
3022explain at least 50% of the underlying genetic defects. This
conclusion will be strengthened upon the analysis of more
families, both in the Indonesian and in other populations.
Taken together, the results described in this study have
helped  to  clarify  the  molecular  genetic  causes  underlying
recessive RP in Indonesia and as such will be beneficial in
terms of genetic counseling, disease diagnosis, and/or disease
prognosis  and  in  the  future  might  help  to  select  patients
eligible for genetic therapies to cease the progression of this
disabling disease.
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